-18%

est. 2Y upside i

Healthcare

Rank

#2730

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Low

Due to complete lack of financial data, equity upside cannot be reliably estimated.

Last updated: July 3, 2026

Bull (15%)+80%

Nym achieves market leadership with CLU moat, IPO within 2 years at ~$600M valuation, driven by large TAM and customer wins. After 20% dilution, net upside ~80%.

Base (55%)0%

Steady growth at 30% YoY, but multiple compression and dilution offset gains; equity value roughly flat at ~$300M entry valuation.

Bear (30%)-100%

Incumbent threat (Optum/Epic) materializes, adoption stalls, next round down-rounds; common stock wiped out by $92M preference stack.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

0%

Total preferred liquidation preference of $92M likely exceeds 30% of fair value given estimated valuation ~$300M, resulting in severe common dilution in exit.

Dilution Risk

high

Lack of revenue data suggests cash burn requires another raise within 24 months, diluting existing equity by ~20%.

Secondary Liquidity

none

No secondary market activity reported; equity is illiquid until exit.

Questions to Ask at the Interview

Strategic questions based on Nym's data — designed to show you've done your homework.

  • 1

    “What specific revenue growth rate and gross margin does Nym currently achieve, and how does unit economics improve with scale?”

  • 2

    “How does Nym's CLU moat hold up if Epic or Optum build native AI coding, and what is the switching cost for customers?”

  • 3

    “Given the CEO transition and no disclosed financials, what milestones would trigger a liquidity event, and how is employee equity valued currently?”

Community

Valuation Sentiment

Our model estimates -18% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.